LEADER 01970nam  2200577Ia 450 
001 9910456058903321
005 20200520144314.0
010   $a1-280-17671-7
010   $a9780309527813
010   $a9786610176717
010   $a0-309-52781-3
035   $a(CKB)111087027010014
035   $a(OCoLC)70749613
035   $a(CaPaEBR)ebrary10049206
035   $a(SSID)ssj0000176892
035   $a(PQKBManifestationID)11165721
035   $a(PQKBTitleCode)TC0000176892
035   $a(PQKBWorkID)10206485
035   $a(PQKB)11347617
035   $a(MiAaPQ)EBC3375900
035   $a(Au-PeEL)EBL3375900
035   $a(CaPaEBR)ebr10049206
035   $a(CaONFJC)MIL17671
035   $a(OCoLC)923259831
035   $a(EXLCZ)99111087027010014
100   $a20040218d2004      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunization safety review$b[electronic resource] $einfluenza vaccines and neurological complications /$fImmunization Safety Review Committee, Board on Health Promotion and Disease Prevention ; Kathleen Stratton ... [et al.], editors, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (190 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-09086-5 
320   $aIncludes bibliographical references.
606   $aInfluenza vaccines$xSide effects
606   $aNervous system$xDiseases$xImmunological aspects
608   $aElectronic books.
615  0$aInfluenza vaccines$xSide effects.
615  0$aNervous system$xDiseases$xImmunological aspects.
676   $a614.5/18
701   $aStratton$b Kathleen R$0857330
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456058903321
996   $aImmunization safety review$92294709
997   $aUNINA